Module 2

Question 1

Defined as ‘a structured, critical examination of a patient’s medicines

Answer 1

Medication review

Question 2

Key part of good prescribing process

Answer 2

Regular review of medicine

Question 3

Important as evidence suggest being in multiple medicines increases patients risk/harm

Answer 3

Polypharmacy

Question 4

enable patients on long-term regular medication to obtain further supplies

Answer 4

Repeat prescribing system

Question 5

required for this repeat prescribing to ensure the safe and efficient use of medicines

Answer 5

Robust system

Question 6

Can vary from simple review of prescription to an in-depth structured clinical medication review

Answer 6

Medication review

Question 7

Should be carried out by a healthcare professional

Answer 7

Structured medication review

Question 8

Types of f medication review

Answer 8

Prescription review
Treatment review
Clinical review

Question 9

systematic method for
recording the pharmacist’s examination

Answer 9

Pharmaceutical care

Question 10

It encompasses a complete and comprehensive archive of the patient’s drug-related
information, a record of pharmaceutical care interventions, and all care plans and outcomes, and
it also may serve as a legal record of the care

Answer 10

Documentation system

Question 11

care is integral to the continuity of care
demonstration of clinician competence

Answer 11

Documentation of pharmaceutical care

Question 12

Symptoms the patient or caregiver verbally expresses.

Answer 12

Subjective

Question 13

Measurements that are observed (seen, heard, touched, smelled) by the
clinician. Examples include vital signs, pulse, temperature, skin color, edema, and
diagnostic testing.

Answer 13

Objective

Question 14

A prioritized list of assessed patient conditions. This may consist of the level
of control, differentials, potential confounders to control, pertinent positive or negative signs
and symptoms related to the condition, reference to evidence-based medicine goals,
considerations for pharmacotherapy, and adjunctive lifestyle measures.

Answer 14

Assessment

Question 15

Care plan action steps for the patient and healthcare practitioners. These steps may
include requests for laboratory or diagnostic assessments.

Answer 15

Plan

Question 16

constructed in the manner described identifies each drug-related problem
and states the clinical pharmacist’s findings observed

Answer 16

FARM progress notes

Question 17

A summary of the pertinent information obtained after collection and through
assessment of patient information

Answer 17

Findings

Question 18

Pharmacist’s evaluation of the present situation. It should delineate the
thought process that led to the conclusion on problem whether it did or did not exist and
active intervention either was or was not necessary

Answer 18

Assessment

Question 19

Highlights the actions proposed to resolve drug related problem based upon
preceding analysis. Common recommendations include non-pharmacologic therapy like
dietary modifications or assisting devices.

Answer 19

Resolution

Question 20

must mention a specific
drug, dose, route, schedule and duration of therapy.

Answer 20

Pharmacologic therapy

Question 21

A plan for follow-up monitoring of the patient must be documented and
adequately implemented which includes questioning the patient, gathering laboratory data,
performing ongoing physical assessments necessary to determine effect of the plan.

Answer 21

Monitoring

Question 22

Level 1 is also known as what?

Answer 22

Prescription review

Question 23

Level 2 is also known as what?

Answer 23

Treatment review